Group One Trading’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$528K Buy
+82,810
New +$528K ﹤0.01% 660
2025
Q1
Sell
-37,609
Closed -$360K 2437
2024
Q4
$360K Sell
37,609
-8,000
-18% -$76.5K ﹤0.01% 732
2024
Q3
$381K Buy
+45,609
New +$381K ﹤0.01% 554
2024
Q2
Hold
0
2151
2024
Q1
Sell
-273,774
Closed -$657K 2181
2023
Q4
$657K Buy
273,774
+83,133
+44% +$200K ﹤0.01% 480
2023
Q3
$648K Buy
190,641
+188,920
+10,977% +$642K ﹤0.01% 466
2023
Q2
$12.6K Buy
1,721
+1,389
+418% +$10.2K ﹤0.01% 1275
2023
Q1
$3.44K Sell
332
-10,629
-97% -$110K ﹤0.01% 1493
2022
Q4
$129K Buy
10,961
+8,844
+418% +$104K ﹤0.01% 840
2022
Q3
$44K Sell
2,117
-6,200
-75% -$129K ﹤0.01% 1267
2022
Q2
$258K Buy
8,317
+3,414
+70% +$106K ﹤0.01% 795
2022
Q1
$201K Sell
4,903
-6,211
-56% -$255K ﹤0.01% 1032
2021
Q4
$483K Sell
11,114
-8,459
-43% -$368K ﹤0.01% 904
2021
Q3
$980K Buy
19,573
+3,300
+20% +$165K ﹤0.01% 628
2021
Q2
$1.03M Buy
16,273
+12,005
+281% +$756K ﹤0.01% 595
2021
Q1
$397K Sell
4,268
-10,386
-71% -$966K ﹤0.01% 837
2020
Q4
$1.31M Sell
14,654
-12,874
-47% -$1.15M ﹤0.01% 408
2020
Q3
$2.84M Buy
+27,528
New +$2.84M 0.01% 188
2020
Q2
Hold
0
1645
2018
Q4
Sell
-200
Closed -$13K 1545
2018
Q3
$13K Buy
+200
New +$13K ﹤0.01% 1165
2017
Q4
Hold
0
1514
2017
Q3
Sell
-2,500
Closed -$85K 1451
2017
Q2
$85K Buy
+2,500
New +$85K ﹤0.01% 778
2017
Q1
Sell
-1,400
Closed -$46K 1402
2016
Q4
$46K Buy
1,400
+1,300
+1,300% +$42.7K ﹤0.01% 841
2016
Q3
$3K Sell
100
-1,100
-92% -$33K ﹤0.01% 1095
2016
Q2
$34K Buy
+1,200
New +$34K ﹤0.01% 806